Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder Oct 18, 2022 04:05PM
Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code Sep 5, 2022 10:19PM
Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction Aug 18, 2022 04:05PM
Clarus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results Mar 30, 2022 04:05PM